Investors Overview

Press Release

View printer-friendly version

BD Board Declares Dividend

FRANKLIN LAKES, N.J., Jan. 27, 2015 /PRNewswire/ -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of 60 cents per common share, payable on March 31, 2015 to holders of record on March 10, 2015. The indicated annual dividend rate is $2.40 per share.

About BD
BD is a leading medical technology company that partners with customers and stakeholders to address many of the world's most pressing and evolving health needs. Our innovative solutions are focused on improving drug delivery, enhancing the diagnosis of infectious diseases and cancers, supporting the management of diabetes and advancing cellular research. We have more than 30,000 associates in 50 countries who strive to fulfill our purpose of "Helping all people live healthy lives" by advancing the quality, accessibility, safety and affordability of healthcare around the world. For more information, please visit www.bd.com.

Contact:
Ed Cook, Corporate Communications – 201-847-7176
Monique N. Dolecki, Investor Relations – 201-847-5378

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/bd-board-declares-dividend-300026217.html

SOURCE BD (Becton, Dickinson and Company)

Investor Highlights

Placeholder

Meet Jonathan

Moments after crossing the finish line of a half marathon, Jonathan went into cardiac arrest due to a congenital defect in his artery.
Placeholder

Drone Delivery Capabilities

See how BD and WeRobotics worked to advance drones for healthcare in the Peruvian Amazon
Placeholder

AMR Leadership

BD solutions to combat antimicrobial resistance

© 2019 BD. All rights reserved. Unless otherwise noted, BD, the BD Logo and all other trademarks are property of Becton, Dickinson and Company.